| Literature DB >> 26697185 |
Yidan D Zhao1, Jenny Peng1, Elise Granton1, Kathleen Lin1, Catherine Lu1, Licun Wu1, Tiago Machuca1, Thomas K Waddell1, Shaf Keshavjee1, Marc de Perrot1.
Abstract
This study was undertaken to characterize the molecular and pathological mechanisms of pulmonary vascular remodeling in a patient who developed chronic lung allograft dysfunction and recurrent pulmonary hypertension (PH) 22 years after undergoing a right single lung transplantation for pulmonary arterial hypertension (PAH). Histopathologic examination of the explanted lungs at the time of retransplantation showed characteristics of diffuse vascular remodeling combined with features of acute and chronic thromboemboli and evidence of bronchiolitis obliterans in the right lung allograft. In contrast, the native left lung demonstrated pulmonary arterial changes in keeping with PAH associated with disseminated pulmonary ossification. Real-time polymerase chain reaction and Western blot-performed on the first lung allograft, the native lung, and the new donor lung-demonstrated increased expression of apoptotic-related gene and protein levels in the lung allograft compared with the native PAH lung and the donor lung. Localization of cell apoptosis determined by triple immunostaining for caspase 3, CD31, and smooth muscle actin was positive in the pulmonary endothelial cells but not the smooth muscle cells of the lung allograft, while no positive staining was detected for cell death in the native PAH lung. The presence of PH in the lung allograft 22 years after transplantation was associated with upregulation of apoptotic markers and evidence of apoptotic endothelial cell death compared with the native lung and donor lung.Entities:
Keywords: apoptosis; proliferation; pulmonary hypertension; reoccurrence
Year: 2015 PMID: 26697185 PMCID: PMC4671752 DOI: 10.1086/683692
Source DB: PubMed Journal: Pulm Circ ISSN: 2045-8932 Impact factor: 3.017